Search

everythinglearnresearchcommunity

for

Search:↓

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Melatonin stops melanin production after tyrosinase action, with cyclic GMP mimicking this effect.

The data suggests that dosing differences can help manage spasticity in patients with upper motor neuron dysfunction.

Certain drugs can cause early hair growth in mice by affecting the nerves.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Pramipexole can cause side effects like dizziness, sleepiness, hallucinations, and low blood pressure, and it's important to educate patients and keep doses low.

Combining tadalafil and finasteride improves their solubility and effectiveness.

New molecules can prevent cell death in hair follicles.

The research found a link between certain molecular features and the biological activity of BC3, which can help identify or create new active compounds.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

New Finasteride conjugate improves prostate treatment and vital signs in rats.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Marine sponges from Tabuhan Island can inhibit enzymes linked to Alzheimer's and hair loss.

β-estradiol slows hair growth in mice.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Potassium channel openers like minoxidil boost hair growth.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

Finasteride boosts morphine's pain relief and prevents tolerance and withdrawal in rats.

Finasteride boosts morphine's pain relief, stops tolerance, and reduces withdrawal in rats.

PEA reduces pain by increasing neurosteroid synthesis in the spinal cord.

Neuroactive steroids affect cocaine's rewarding effects through the ς₁ receptor.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.